AEON Biopharma (NASDAQ:AEON – Free Report) had its price objective reduced by HC Wainwright from $18.00 to $6.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a buy rating on the stock. AEON Biopharma Stock Down 2.5 % AEON traded down $0.04 during midday trading on Wednesday, reaching $1.54. […]
Promising Combination Therapy for Tripple Negative Breast Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, Potential Income of $13 75M and Royalties of up to $12 50M - Form 8-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Baystreet ca - Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer
baystreet.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baystreet.ca Daily Mail and Mail on Sunday newspapers.
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
USA News Group: Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.